Galderma Laboratories Inc.

Galderma Research & Development Snc

Galderma Research & Development

Galderma S.a.

Philip Freidenreich

Michael Graeber

Christian Loesche

Matthew James Leoni

Yin-sang Liu

Jack A DeJovin

Isabelle Jean DeJovin

Yin-Sang Liu

Yin Liu

Jean-Pierre Etchegaray

Sandrine Segura

Ludovic Bussard

Vasant Kumar Manna

Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.

Methods and compositions for safe and effective treatment of erythema

Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.

Methods and compositions for safe and effective treatment of telangiectasia

Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one &#x3b1;-adrenergic receptor agonist and a pharmaceutically acceptable carrier.

Methods and compositions for treating or preventing erythema

Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.

Growing community of inventors

Yardley, PA, United States of America

Philip Freidenreich